An inhibitory effect on cancer progression by re-expression of HAI2 has been reported in various cancers, including HCC, medulloblastoma, glioblastoma, breast cancer, melanoma, cervical cancer, ovarian cancer, and RCC [14]. This evidence concerns the gene SPINT2 and breast cancer.